Spektus Pharma

Spektus is a specialty pharmaceutical company dedicated to developing and delivering value-added medicines for the Central Nervous System (CNS) segment. Our portfolio addresses unmet needs in depression, ADHD, and pain, with a pipeline of differentiated oral drugs built using our proprietary drug-delivery platforms. At the heart of our innovation is Flexitab®, a patented breakable extended-release platform that enables clinically meaningful benefits and new label opportunities for established molecules. Headquartered in Laval, Quebec, Spektus operates its own R&D facilities and partners globally with leading pharmaceutical companies, with a primary focus on the North American and European markets.